Sherman Oaks, California Clinical Trials

A listing of Sherman Oaks, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1490 clinical trials
featured
C2541013 MIRNA NASH  

The study aims to evaluate two, orally administered, investigational agents - PF-06865571 (DGAT2 inhibitor) and the coadministration of PF-06865571 with PF-05221304 (ACC inhibitor). This study is specifically designed to evaluate the effect of a range of doses of DGAT2i alone, and DGAT2i + ACCi, on resolution of NASH or improvement …

ASCLEPES Research Centers, P.C.
 (5.3 away)
  • 261 views
  • 10 Jun, 2021
  • +58 other locations
featured
ECOSPOR III: A Phase 3 Multicenter, RandomizeEd, Double Blind, Placebo COntrolled, Parallel Group Study to Evaluate the Safety, Tolerability, & Efficacy of SER-109 vs. Placebo to Reduce Recurrence of ClOstRidium Difficile Infection (CDI) in Adults

ECOSPOR III is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the safety, tolerability, and efficacy of SER-109 versus placebo in adult subjects 18 years of age or older with recurrent CDI, defined as: a history of ≥ 3 CDI episodes within 9 months, inclusive of the current …

vancomycin
antibiotics
fidaxomicin
clostridium difficile
antibiotic therapy
California Medical Research Associates Inc
 (8.1 away) Contact site
  • 1092 views
  • 21 Dec, 2020
  • +71 other locations
featured
ECOSPOR IV: An Open-Label Extension of Study SERES-012 and Open-Label Program for Evaluating SER-109 in Adult Subjects with Recurrent Clostridioides difficile Infection (RCDI)

ECOSPOR IV is a Phase 3, multicenter, Open Label study to evaluate the safety and tolerability of SER-109 in adult subjects with recurrent CDI.

clostridium difficile
California Medical Research Associates, Inc.
 (8.3 away) Contact site
  • 37 views
  • 21 Dec, 2020
  • +76 other locations
featured
A Randomized, Double-Blind, Dose-Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

A Randomized, Double-Blind, Dose-Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

vitiligo
THE VITILIGO & PIGMENTATION INSTITUE OF SOUTHERN CALIFORNIA
 (8.0 away) Contact site
  • 9156 views
  • 15 Dec, 2020
  • +14 other locations
featured
Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies

The study will determine Recommended Phase 2 Dose for all study drugs, based on the safety and tolerability of the following combinations: INCAGN02385 + INCAGN02390 and INCAGN02385 + INCAGN02390 + INCMGA00012.  

THE ANGELES CLINIC AND RESEARCH INSTITUTE
 (7.1 away) Contact site
  • 0 views
  • 04 Aug, 2020
  • +2 other locations
featured
[Remote] Beyond Listening: A music-based intervention

1.This study is for people with dementia and their family caregiver. 2. The intervention is a 6-week psychoeducational, music-based workshop designed for caregivers of PWD. The caregiver will attend a one-hour, online session for 6 consecutive weeks. Caregivers will implement a daily caregiving routine that incorporates singing, music with movement and …

[Remote] Beyond Listening: A music-based intervention
 (6.4 away) Contact site
  • 0 views
  • 04 May, 2021
  • +240 other locations
featured
[ONLINE] SPEECH BIOMARKERS: NEUROCOGNITIVE FUNCTIONING IN HEALTHY ADULTS

The Frontotemporal Degeneration Center and the Linguistic Data Consortium at the University of Pennsylvania are working to develop simple, easy, and effective ways to track neurocognitive health through short interactions with a web app. You can help us create a large open dataset, which researchers all over the world will …

Online238
 (6.4 away) Contact site
  • 635 views
  • 22 Oct, 2020
  • +251 other locations
featured
[ONLINE] Genetic Testing for Common Disorders: Learning from the Experiences of Individuals who were Tested to Determine their Genetic Risk for Alzheimer’s Disease

This study is looking for people who have the APOE-e4 gene, which is associated with a higher risk for developing Alzheimer’s disease. The study is interested in learning about participants’ experiences. Contact Person Doris T. Zallen 540-231-4216dtzallen@vt.edu IMPORTANT: This communication is meant only to make you aware of an opportunity …

Online238
 (6.4 away) Contact site
  • 424 views
  • 17 Nov, 2020
  • +251 other locations
featured
[ONLINE] Dementia dogs: Their impact on community-dwelling persons with mild to moderate dementia

  This study is looking for pairs of participants: a person with mild-to-moderate dementia, and their caregiver. The study is interested in the difference that dogs can make in participants’ lives. Contact Person Frederic Dumont 1 418 529-9141 ext 6033frederic.dumont@cirris.ulaval.ca

moderate dementia
Online238
 (6.4 away) Contact site
  • 20 views
  • 12 Oct, 2020
  • +250 other locations
featured
[ONLINE] Training Emotion Regulation via Mobile Intervention

This study is looking for Alzheimer’s caregivers. The study is interested in the relationship between emotions and stress.

Online238
 (6.4 away) Contact site
  • 1831 views
  • 05 Oct, 2020
  • +252 other locations